At a lower total dose of 0.1 mg/mouse of crocidolite, the median survival was 73 weeks in Bap1-mutant mice and 83 weeks in WT mice (P < 0.01, log-rank test), and the incidence of MM was 47% (9/19 mice) in Bap1+/− mice compared with only 13% (2/16) in Bap1+/+ mice (Fisher exact test, P < 0.03; Fig. 1B). The gene discussed is BAP1; the disease is Miyoshi myopathy.